Mohr Davidow Ventures
Description
Mohr Davidow Ventures (MDV) was a pioneering Silicon Valley venture capital firm, established in 1983 by Alan Mohr and Nancy Davidow. For nearly three decades, MDV played a significant role in fostering innovation by investing in early-stage technology-based startups with the potential to create large new markets. The firm's investment thesis spanned a wide array of sectors, including software, internet, communications, life sciences, and clean technology, reflecting the evolving landscape of technological advancement.
MDV was known for its hands-on approach and commitment to building foundational companies. Over its history, the firm successfully raised multiple funds, with its final fund, MDV X, closing at $300 million in 2007. This capital was deployed to back promising ventures, contributing to the growth of numerous successful enterprises. Notable companies in their portfolio included Brocade Communications, Critical Path, Shutterfly, and Rocket Fuel, which went public.
The firm ceased making new investments around 2013-2014, shifting its focus to managing its existing portfolio and supporting its remaining companies through to successful exits. One significant exit was Ticketfly, an online ticketing platform acquired by Pandora for $450 million. While no longer actively investing in new startups, Mohr Davidow Ventures left a lasting legacy as an influential early-stage investor that helped shape the modern technology ecosystem.
Investor Profile
Mohr Davidow Ventures has backed more than 308 startups, with 0 new investments in the last 12 months alone. The firm has led 91 rounds, about 30% of its total and boasts 84 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, Canada, France.
- Strong thematic focus on Software, Information Technology, Health Care.
- Typical check size: $2M – $10M.
Stage Focus
- Series B (23%)
- Series A (20%)
- Series C (18%)
- Series Unknown (12%)
- Series D (8%)
- Seed (7%)
- Series E (5%)
- Private Equity (4%)
- Series F (2%)
- Debt Financing (1%)
Country Focus
- United States (96%)
- Canada (2%)
- France (1%)
- United Kingdom (1%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Software
- Information Technology
- Health Care
- Enterprise Software
- Biotechnology
- Analytics
- Saas
- Health Diagnostics
- Manufacturing
- Fintech
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
